Table 3.
STRING: Biological Processes (GO), Molecular Function (GO), Cellular Components with KEGG, and Reactome Pathway for the NIPA1 Gene.
GO-term | Description | Count in Gene Set | False Discovery Rate |
---|---|---|---|
Biological Process (GO) | |||
GO:0030509 | BMP signaling pathway | 10 of 92 | 3.30 × 10−15 |
GO:0010862 | Positive regulation of pathway restricted SMAD protein phosphorylation | 9 of 49 | 3.30 × 10−15 |
GO:0061448 | Connective tissue development | 11 of 194 | 7.18 × 10−15 |
GO:0030501 | Positive regulation of bone mineralization | 8 of 35 | 1.05 × 10−14 |
GO:0051216 | Cartilage development | 10 of 147 | 3.31 × 10−15 |
Molecular Function (GO) | |||
GO:0005160 | Transforming growth factor beta receptor binding | 7 of 50 | 1.37 × 10−11 |
GO:0070700 | BMP receptor binding | 5 of 9 | 9.71 × 10−11 |
GO:0019199 | Transmembrane receptor protein kinase activity | 6 of 78 | 5.79 × 10−9 |
GO:0008083 | Growth factor activity | 7 of 160 | 5.79 × 10−9 |
GO:0005125 | Cytokine activity | 7 of 216 | 3.33 × 10−8 |
Cellular Component (GO) | |||
GO:0043025 | Neuronal cell body | 6 of 460 | 0.00089 |
GO:1990712 | HFE-transferrin receptor complex | 2 of 8 | 0.0026 |
GO:0005615 | Extracellular space | 7 of 1134 | 0.0031 |
GO:0030425 | Dendrite | 5 of 531 | 0.0048 |
GO:0043235 | Receptor complex | 4 of 305 | 0.0052 |
KEGG Pathways | |||
HSA04350 | TGF-beta signaling pathway | 9 of 83 | 5.28 × 10−15 |
HSA04390 | Hippo signaling pathway | 9 of 152 | 4.68 × 10−13 |
HSA04060 | Cytokine–cytokine receptor interaction | 6 of 263 | 3.07 × 10−6 |
HSA04360 | Axon guidance | 5 of 173 | 8.95 × 10−6 |
Reactome Pathways | |||
HSA201451 | Signaling by BMP | 5 of 27 | 9.97 × 10−9 |
HAS9006936 | Signaling by TGF-beta family members | 6 of 100 | 3.10 × 10−8 |
HSA2129379 | Molecules associated with elastic fibers | 4 of 37 | 2.03 × 10−6 |
HSA1474244 | Extracellular matrix organization | 5 of 298 | 0.00017 |
HSA8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 2 of 30 | 0.0055 |
Source: STRING.org.